Alnylam Pharmaceuticals, Inc.

Swedbank AB ALNY
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/9/2026
Shares
61,942
Value ($000)
24,631
Weight
0.0%
2021 Q1 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).